NMPA Unveils 82nd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has announced the release of the 82nd batch of...
Policy / Regulatory
Hainan Province Unveils Ambitious Three-Year Plan for Digital Health Innovation and Economy Expansion
HAIKOU—The People’s Government of Hainan Province has unveiled the “Hainan Province’s Three Year Action Plan...
China Expands Medical Insurance Coverage to Include Assisted Reproductive Technology in 19 Regions
BEIJING—As of September 1, 2024, a total of 19 provinces, municipalities, and the Xinjiang Production...
China’s NMPA Suspends Dr. Reddy’s Atomoxetine Imports Amid Quality Concerns
BEIJING—The National Medical Products Administration (NMPA) has issued a notification to immediately suspend the import,...
China’s Healthcare Statistics Show Improvements in Life Expectancy and Access to Medical Services
BEIJING—The National Health Commission (NHC) of China has published the “China’s Healthcare Statistical Communique 2023,”...
Jiangxi Healthcare Security Administration Launches Initiative to Widen Drug Availability
JIANGXI—In a strategic move to enhance drug accessibility, the Healthcare Security Administration (HSA) bureau of...
China’s New Medical Device Regulations: A Comprehensive Framework for Industry Growth and Safety
BEIJING—China’s National Medical Products Administration (NMPA) has unveiled a draft proposal for the “Medical Device...
NHSA Updates NRDL Review, Adds Three Domestic Western Medicines
The National Healthcare Security Administration (NHSA) has issued a notification regarding the review and correction...
China to Enhance Basic Medical Insurance Coverage for Residents in 2024 with Increased Subsidies and Personal Payments
The National Healthcare Security Administration (NHSA), in conjunction with the Ministry of Finance and State...
China’s NHC and NHSA Intensify Efforts to Stabilize Drug Supply and Prices Amid Shortages
The National Health Commission (NHC) has published a report titled “Recent Work on Securing Supply...
China Commits to Optimizing Market Access for Emerging Sectors and Global Scientific Collaboration
The General Office of the Communist Party of China (CPC) Central Committee and the State...
US Congressmen Call for FDA Investigation into Clinical Trials at China’s Military Hospitals
US lawmakers are intensifying their scrutiny of the involvement of Chinese military hospitals in hosting...
China’s VBP Office Exposes Collusion Among Six Firms in Bromhexine Bidding Process
The National Drug Alliance Procurement Office, which oversees the Volume-Based Procurement (VBP) program, has issued...
US Congress Seeks FDA Action on China Military Hospital Trials and Biopharma Security
WASHINGTON—In an unprecedented move, US congressmen have intensified their demands for the US Food and...
China’s National Drug Alliance Procurement Office Imposes Sanctions on Six Firms Over Collusion in Bromhexine Bidding
BEIJING—The National Drug Alliance Procurement Office, which oversees the Volume-Based Procurement (VBP) program, has announced...
NHSA Flags Concerns Over Pricing of MicroPort’s Castor Aortic Stent Graft System
BEIJING—The National Healthcare Security Administration (NHSA) has issued an open letter expressing concerns over the...
Beijing Proposes New Regulations to Enhance Pharmaceutical Retail Standards and Services
The Beijing Municipal Medical Products Administration has unveiled a draft proposal titled “Guiding Opinions on...
Shaanxi Leads New Provincial Alliance for Volume-Based Procurement of Medical Products
The Shaanxi Public Resources Trading Center has announced the formation of a provincial alliance for...
China’s SAMR Proposes Antitrust Guidelines to Regulate Pharmaceutical Industry
The State Administration for Market Regulation (SAMR) in China has unveiled a draft proposal for...
NHSA Preliminary Review Identifies Potential NRDL Additions, Including Novel Therapies and ADCs
The National Healthcare Security Administration (NHSA) has released a preliminary list of drugs that have...